![](/img/cover-not-exists.png)
Efficacy of alirocumab according to background statin intensity and other lipid-lowering therapy in heterozygous familial hypercholesterolemia or high cv risk populations: phase 3 sub-group analyses
Krempf, M., Bergeron, J., Elassal, J., Minini, P., Miller, K., Kastelein, J.J.P.Volume:
241
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2015.04.087
Date:
July, 2015
File:
PDF, 277 KB
english, 2015